Cutting-edge apoptosis-based therapeutics: a panacea for cancer?

Cutting-edge apoptosis-based therapeutics: a panacea for cancer?

Item
http://www.wikidata.org/entity/Q36951942
Allosteric regulation of protease activity by small molecules.Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.Targeting AAC-11 in cancer therapy.Mitochondria in cancer: at the crossroads of life and deathOxidative stress in apoptosis and cancer: an update.Diterpenylhydroquinones from natural ent-labdanes induce apoptosis through decreased mitochondrial membrane potential.Pan-BH3 mimetic S1 exhibits broad-spectrum antitumour effects by cooperation between Bax and Bak.A novel BH3 mimetic S1 potently induces Bax/Bak-dependent apoptosis by targeting both Bcl-2 and Mcl-1.Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer
P2860

Cutting-edge apoptosis-based therapeutics: a panacea for cancer?

Item
http://www.wikidata.org/entity/Q36951942
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cutting-edge apoptosis-based therapeutics: a panacea for cancer?
@en
type
label
Cutting-edge apoptosis-based therapeutics: a panacea for cancer?
@en
prefLabel
Cutting-edge apoptosis-based therapeutics: a panacea for cancer?
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
Cutting-edge apoptosis-based therapeutics: a panacea for cancer?
@en
P2093
P2860
P2888
P304
P31
P356
10.2165/00063030-200721050-00001
P433
P478
P577
P6179
P698